Skip to main content
logo
Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
35.68
+0.95 (2.72%)
Jun 30, 2026, 1:50 PM EDT - Market open

Roivant Sciences Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
-397.91-356.734,231-1,115-924.12
Depreciation & Amortization
3.3514.0722.0418.865.93
Stock-Based Compensation
346.17289.03199.63217.78564.96
Other Adjustments
-80.16-708.77-5,23729.09-340.22
Changes in Accounts Payable
3.42-18.1722.684.3615.4
Changes in Accrued Expenses
59.33-10.0762.1357.5350.6
Changes in Income Taxes Payable
85.05-10.059.93--
Changes in Other Operating Activities
-769.59-38.76-75.7-55.54-50.28
Operating Cash Flow
-750.35-839.45-765.27-843.39-677.73
Capital Expenditures
-8.21-4.6-1.38-12.69-17.44
Purchases of Investments
-4,796-4,062---
Proceeds from Sale of Investments
4,1291,960-114.56320.17
Proceeds from Business Divestments
-370.975,281--
Other Investing Activities
-6.94-31.14-75.89-146.140.56
Investing Cash Flow
-682.33-1,7665,204-44.27303.3
Long-Term Debt Issued
---159.936.4
Long-Term Debt Repaid
--52.75-30.71-30.14-21.59
Net Long-Term Debt Issued (Repaid)
--52.75-30.71129.7614.81
Issuance of Common Stock
269.5150.63255.09315.11313.84
Repurchase of Common Stock
-366.72-1,330-37.76-10.88-
Net Common Stock Issued (Repurchased)
-97.22-1,280217.34304.23313.84
Other Financing Activities
231.46112.78232.7365.48-21.85
Financing Cash Flow
134.24-1,220419.36499.46306.79
Effect of Exchange Rate Changes on Cash and Cash Equivalents
3.770.750.626.28-
Net Cash Flow
-1,295-3,8254,858-381.92-67.64
Free Cash Flow
-758.56-844.05-766.65-856.08-695.17
FCF Margin
-9183.51%-2905.21%-2343.56%-1397.00%-1257.40%
Free Cash Flow Per Share
-1.09-1.16-0.92-1.20-1.04
Levered Free Cash Flow
-926.43-292.314,358-866.76-826.24
Unlevered Free Cash Flow
-1,401-1,1424,516-1,168-1,348
SEC Filings: 10-K · 10-Q